HighTower Advisors LLC raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 212.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,422 shares of the company's stock after acquiring an additional 11,850 shares during the quarter. HighTower Advisors LLC's holdings in Bath & Body Works were worth $528,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Victory Capital Management Inc. lifted its stake in shares of Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after buying an additional 6,752,274 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in shares of Bath & Body Works by 9.8% in the first quarter. Bank of New York Mellon Corp now owns 2,274,388 shares of the company's stock worth $68,959,000 after buying an additional 203,724 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Bath & Body Works by 50.4% in the fourth quarter. Bank of America Corp DE now owns 1,741,712 shares of the company's stock worth $67,526,000 after buying an additional 583,337 shares during the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Bath & Body Works by 3,642.2% in the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after buying an additional 1,606,988 shares during the last quarter. Finally, Balyasny Asset Management L.P. lifted its stake in shares of Bath & Body Works by 36.1% in the fourth quarter. Balyasny Asset Management L.P. now owns 1,437,418 shares of the company's stock worth $55,729,000 after buying an additional 380,942 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Bath & Body Works Stock Up 3.6%
Bath & Body Works stock traded up $1.09 on Thursday, hitting $31.65. The company's stock had a trading volume of 1,316,125 shares, compared to its average volume of 5,194,774. The firm has a market cap of $6.53 billion, a P/E ratio of 9.39, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49. The company has a fifty day moving average price of $30.69 and a 200-day moving average price of $30.68. Bath & Body Works, Inc. has a one year low of $24.94 and a one year high of $41.87.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.37. The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business's revenue for the quarter was down .8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's payout ratio is 23.74%.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on BBWI shares. The Goldman Sachs Group reduced their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Wells Fargo & Company upped their target price on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, May 14th. Barclays upped their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a research note on Friday, August 29th. Telsey Advisory Group reiterated an "outperform" rating and set a $38.00 target price on shares of Bath & Body Works in a research note on Thursday, August 28th. Finally, Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and a consensus target price of $41.62.
View Our Latest Report on Bath & Body Works
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.